Our recent study revealed significantly higher expression of TRAIL-R1 in tumor tissue of pancreatic ductal adenocarcinoma patients (PDAC) as compared to non-neoplastic adjacent tissue [48]. Here, TNFRSF10A is linked to pancreatic ductal adenocarcinoma.